Philadelphia, PA (PRWEB) October 31, 2012
Verified Clinical Trials (VCT) was a sponsor and exhibitor at the GBX Summit in Philadelphia, PA this past week. While at the conference, Verified Clinical Trials spoke to the issues surrounding dual enrollment in clinical trials and the professional research subject with many of the industry's top executives from the most formidable research and pharmaceutical companies. These discussions included the concerns surrounding clinical research safety and data quality.
Mitchell Efros MD FACS, reviewed the challenges detecting these individuals in clinical trials and thwarting their participation in multiple trials simultaneously or commencing a new trial prior to the determined safe washout period. Dr. Mitchell Efros, CEO of Verified Clinical Trials (VCT), described methods to detect professional research subjects and dual enrollment by use of the unified clinical trial database registry that VCT offers as a means to discover these individuals and improve clinical trial research subject safety and data quality. Verified Clinical Trials (VCT) is the largest North American clinical trials database registry. Because VCT is 100% web based, the system is scalable and affordable without the need to purchase and install software or hardware. This allows VCT to focus on both early phase and late phase trials improving the coverage and worth of the entire database. Coverage with the VCT database system includes large research facilities and thousands of smaller sites involved in later phase trials as well.
Kerri Weingard ANP COO, added her special expertise and knowledge base with experience from over 20 years in the industry. She stated "the amount of abuse and dual enrollment we are witnessing in the industry is unheralded. The only useful tool we have is with the system that Verified Clinical Trials provides".
Attending the summit were leading members of CRO's, research sites, and pharmaceutical companies. Many of these individuals shared their experiences and concerns regarding trials that are conducted without the use of such a registry. It was agreed that increased vigilance and use of a scalable all inclusive clinical trials database registry, such as Verified Clinical Trials, were essential to improving safety and data quality.
Mitchell Efros MD FACS, the President and CEO of VCT, stated "It is apparent that the professional research subject is not a rare occurrence and that an effective clinical trials database registry must include all phases of clinical research studies. By excluding later phase trials we are not fully protecting our volunteers and the data that we are collecting in the various clinical trials." Dr. Efros estimated, "Nearly 1 billion dollars could be saved if Verified Clinical Trials were on average to eliminate 2 poor quality research subjects from entering the 28,000 clinical trials conducted at an average cost of $15,000 per subject."
About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities. To RSVP or for more information, visit http://www.verifiedclinicaltrials.com.
Verified Clinical Trials Contact Info
Kerri Weingard, ANP, Chief Operating Officer
Verified Clinical Trials +1 516 998-7499